Published in
BMJ Publishing Group, Journal of Neurology, Neurosurgery and Psychiatry, 3(88), p. 196-203, 2016
Links
Tools
Highly active immunomodulatory therapy ameliorates accumulation of disability in moderately advanced and advanced multiple sclerosis.
Journal article published in 2016 by
Nathaniel Lizak,
Alessandra Lugaresi 
,
Raed Alroughani ,
Jeannette Lechner-Scott,
Mark Slee,
Eva Havrdova,
Dana Horakova,
Maria Trojano,
Guillermo Izquierdo,
Pierre Duquette,
Marc Girard,
Alexandre Prat,
Pierre Grammond,
Raymond Hupperts,
Francois Grand'Maison
and other authors.
,
Raed Alroughani ,
Jeannette Lechner-Scott,
Mark Slee,
Eva Havrdova,
Dana Horakova,
Maria Trojano,
Guillermo Izquierdo,
Pierre Duquette,
Marc Girard,
Alexandre Prat,
Pierre Grammond,
Raymond Hupperts,
Francois Grand'Maison
and other authors.
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Published version:
archiving forbidden
Data provided by 
Abstract
To evaluate variability and predictability of disability trajectories in moderately advanced and advanced multiple sclerosis (MS), and their modifiability with immunomodulatory therapy.